Skip to main content
TipRanks
Go Ultimate75% OFF

Joshua Makower Insider Profile

4 Followers

Joshua Makower, Ten Percent Owner at Monte Rosa Therapeutics, holds 7.69M shares in Monte Rosa Therapeutics (Ticker: GLUE), holds 182.44M shares in NeueHealth Inc (Ticker: NEUE), holds 4.52M shares in Eargo (Ticker: EAR).

Joshua Makower's Trading History

NEUE
NeueHealth Inc
Jun 30, 2021―Uninformative Buy―$1.23B
GLUE
Monte Rosa Therapeutics
Jun 30, 2021Ten Percent OwnerUninformative Buy―$70.46M
EAR
Eargo
May 26, 2021―Uninformative Sell―$11.62M
MTCR
Metacrine
Sep 22, 2020―Uninformative Buy―$1.78M
INZY
Inozyme Pharma
Jul 28, 2020―Uninformative Buy―$9.75M
GNCAQ
Genocea Biosciences
Jul 28, 2020―Informative Buy7.09M―
NKTX
Nkarta
Jul 16, 2020Ten Percent OwnerUninformative Buy―$3.51M
AKUS
AKOUOS
Jul 01, 2020―Uninformative Buy―$57.07M
AVEO
AVEO Pharma
Jun 22, 2020―Informative Buy7.50M$59.29M
TRVI
Trevi Therapeutics
Apr 13, 2020Ten Percent OwnerUninformative Buy1.50K$78.92M
ARDX
Ardelyx
Dec 09, 2019Ten Percent OwnerUninformative Buy2.50M$20.15M
MIRM
Mirum Pharmaceuticals
Jul 24, 2019Ten Percent OwnerUninformative Buy―$383.38M
RGLS
Regulus
May 09, 2019―Informative Buy1.23M$16.75M
CASC
Cascadian Therapeutics
Mar 13, 2018―Uninformative Sell―$0.00
ORKA
Oruka Therapeutics
Feb 27, 2018Ten Percent OwnerInformative Sell730.10K$0.00
AKAOQ
Achaogen
Dec 19, 2016―Informative Buy6.75M$117.88K

You May Also Like

Joshua Makower insider profile FAQ

What is the percentage of profitable transactions made by Joshua Makower?
The percentage of profitable transactions made by Joshua Makower is 21%.
What is the average return per transaction made by Joshua Makower?
The average return per transaction made by Joshua Makower is -16.20%.
What stocks does Joshua Makower hold?
Joshua Makower holds: GLUE, ORKA, AVEO, CASC, RGLS, GNCAQ, AKAOQ, ARDX, TRVI, MIRM, AKUS, NKTX, INZY, MTCR, EAR, NEUE stocks.
What was Joshua Makower's most profitable transaction?
Joshua Makower’s most profitable transaction was an Informative Buy of AKAOQ stock on June 7, 2016. The return on the trade was 423.70%.
What is Joshua Makower's role in Monte Rosa Therapeutics?
Joshua Makower's role in Monte Rosa Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.